Document:

<PAGE>

                                                                    Exhibit 10.8

                            OSI PHARMACEUTICALS, INC.
                              AMENDED AND RESTATED
                              STOCK INCENTIVE PLAN
                       (INCLUDING AMENDMENTS NO. 1 AND 2)

1.   PURPOSE

     The purpose of this Amended and Restated Stock Incentive Plan (formerly,
the 2001 Incentive and Non-Qualified Stock Option Plan) (the "Plan") is to
encourage and enable selected management, other employees, directors (whether or
not employees), and consultants of OSI Pharmaceuticals, Inc. (the "Company") or
a parent or subsidiary of the Company to acquire a proprietary interest in the
Company through the ownership, directly or indirectly, of common stock, par
value $.01 per share (the "Common Stock"), of the Company. Such ownership will
provide such employees, directors, and consultants with a more direct stake in
the future welfare of the Company and encourage them to remain with the Company
or a parent or subsidiary of the Company. It is also expected that the Plan will
encourage qualified persons to seek and accept employment with, or become
associated with, the Company or a parent or subsidiary of the Company. As used
herein, the term "parent" or "subsidiary" shall mean any present or future
corporation which is or would be a "parent corporation" or "subsidiary
corporation" of the Company as the term is defined in Section 424 of the Code
(determined as if the Company were the employer corporation).

     Pursuant to the Plan, the Company may grant: (i) Incentive Stock Options;
(ii) Non-Qualified Stock Options; (iii) Stock Appreciation Rights; (iv)
Restricted Stock; and (v) Stock Bonuses, as such terms are defined in Section 2.

2.   DEFINITIONS

     Capitalized terms not otherwise defined in the Plan shall have the
following meanings:

          (a) "Award Agreement" shall mean a written agreement, in such form as
the Committee shall determine, that evidences the terms and conditions of a
Stock Award granted under the Plan.

          (b) "Fair Market Value" on a specified date means the value of a share
of Common Stock, determined as follows:

               (i) if the Common Stock is listed on any established stock
exchange or a national market system, including without limitation The Nasdaq
National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, Inc.,
its Fair Market Value shall be the closing sales price for such stock (or the
closing bid, if no sales were reported) as quoted on such exchange or system on
the day of determination, as reported in The Wall Street Journal or such other
source as the Committee deems reliable;

<PAGE>

               (ii) if the Common Stock is regularly quoted by a recognized
securities dealer but selling prices are not reported, its Fair Market Value
shall be the mean between the high bid and low asked prices for the Common Stock
on the day of determination, as reported in The Wall Street Journal or such
other source as the Committee deems reliable; or

               (iii) in the absence of an established market for the Common
Stock, the Fair Market Value shall be determined in good faith by the Committee.

          (c) "Code" shall mean the Internal Revenue Code of 1986, as amended.

          (d) "Incentive Stock Option" shall mean an option that is an
"incentive stock option" within the meaning of Section 422 of the Code and that
is identified as an Incentive Stock Option in the Award Agreement by which it is
evidenced.

          (e) "Non-Qualified Stock Option" shall mean an option that is not an
Incentive Stock Option within the meaning of Section 422 of the Code.

          (f) "Restricted Stock" shall mean an award of shares of Common Stock
that is subject to certain conditions on vesting and restrictions on
transferability as provided in Section 8 of this Plan.

          (g) "Stock Appreciation Right" shall mean a right to receive payment
of the appreciated value of shares of Common Stock as provided in Section 7 of
this Plan.

          (h) "Stock Award" shall mean an Incentive Stock Option, a
Non-Qualified Stock Option, a Restricted Stock award, a Stock Appreciation Right
or a Stock Bonus award.

          (i) "Stock Bonus" shall mean a bonus award payable in shares of Common
Stock as provided in Section 9 of this Plan.

3.   ADMINISTRATION OF THE PLAN

     The Plan shall be administered by a committee (the "Committee") as
appointed from time to time by the Board of Directors of the Company, which may
be the Compensation Committee of the Board of Directors. Except as otherwise
specifically provided herein, no person, other than members of the Committee,
shall have any discretion as to decisions regarding the Plan. The Company may
engage a third party to administer routine matters under the Plan, such as
establishing and maintaining accounts for Plan participants and facilitating
transactions by participants pursuant to the Plan.

     In administering the Plan, the Committee may adopt rules and regulations
for carrying out the Plan. The interpretations and decisions made by the
Committee with regard to any question arising under the Plan shall be final and
conclusive on all persons participating or eligible to participate in the Plan.
Subject to the provisions of the Plan, the Committee shall determine the terms
of all Stock Awards granted pursuant to the Plan, including, but not limited to,
the persons to whom, and the time or times at which, grants shall be made, the
number of shares to be covered by each Stock Award, and other terms and
conditions of the Stock Award.

                                        2

<PAGE>

4.   SHARES OF STOCK SUBJECT TO THE PLAN

     Except as provided in Section 10, the number of shares that may be issued
or transferred pursuant to Stock Awards granted under the Plan shall not exceed
6,800,000 shares of Common Stock. Such shares may be authorized and unissued
shares or previously issued shares acquired or to be acquired by the Company and
held in treasury. Any shares subject to a Stock Award which for any reason
expires, is cancelled or is unexercised may again be subject to a Stock Award
under the Plan. The aggregate Fair Market Value of the shares with respect to
which Incentive Stock Options (determined at the time of grant of the option)
are exercisable for the first time by an optionee during any calendar year
(under the Plan and all plans of the Company and any parent or subsidiary of the
Company) shall not exceed $100,000.

5.   ELIGIBILITY

     Stock Awards may be granted to directors, officers, employees and
consultants of the Company or a parent or subsidiary of the Company, except that
Incentive Stock Options may not be granted to any such person who is not an
employee of the Company or a parent or subsidiary of the Company.

6.   GRANTING OF OPTIONS

     The Committee may grant options to such persons eligible under the Plan as
the Committee may select from time to time. Such options shall be granted at
such times, in such amounts and upon such other terms and conditions as the
Committee shall determine, which shall be evidenced under an Award Agreement and
subject to the following terms and conditions:

          (a) Type of Option. The Award Agreement shall indicate whether and to
what extent the option is intended to be an Incentive Stock Option or a
Non-Qualified Stock Option.

          (b) Option Price. The purchase price under each Incentive Stock Option
and each Non-Qualified Stock Option shall be not less than 100% of the Fair
Market Value of the Common Stock at the time the option is granted and not less
than the par value of the Common Stock. In the case of an Incentive Stock Option
granted to an employee owning, actually or constructively under Section 424(d)
of the Code, more than 10% of the total combined voting power of all classes of
stock of the Company or of any parent or subsidiary of the Company (a "10%
Stockholder") the option price shall not be less than 110% of the Fair Market
Value of the Common Stock at the time of the grant.

          (c) Medium and Time of Payment. Stock purchased pursuant to the
exercise of an option shall at the time of purchase be paid for in full in cash,
or, upon conditions established by the Committee, by delivery of shares of
Common Stock owned by the recipient. If payment is made by the delivery of
shares, the value of the shares delivered shall be the Fair Market Value of such
shares on the date of exercise of the option. In addition, if the Committee
consents in its sole discretion, an "in the money" Non-Qualified Stock Option
may be exercised on a "cashless" basis in exchange for the issuance to the
optionee (or other person entitled to exercise the option) of the largest whole
number of shares having an aggregate value equal to the

                                        3

<PAGE>

value of such option on the date of exercise. For this purpose, the value of the
shares delivered by the Company and the value of the option being exercised
shall be determined based on the Fair Market Value of the Common Stock on the
date of exercise of the option. Upon receipt of payment and such documentation
as the Company may deem necessary to establish compliance with the Securities
Act of 1933, as amended (the "Securities Act"), the Company shall, without stock
transfer tax to the optionee or other person entitled to exercise the option,
deliver to the person exercising the option a certificate or certificates for
such shares.

          (d) Waiting Period. The waiting period and time for exercising an
option shall be prescribed by the Committee in each particular case; provided,
however, that no option may be exercised after 10 years from the date it is
granted. In the case of an Incentive Stock Option granted to a 10% Stockholder,
such option, by its terms, shall be exercisable only within five years from the
date of grant.

          (e) Non-Assignability of Options. No Incentive Stock Option and,
except as may otherwise be specifically provided by the Committee, no
Non-Qualified Stock Option, shall be assignable or transferable by the recipient
except by will or by the laws of descent and distribution. During the lifetime
of a recipient, Incentive Stock Options and, except as may otherwise be
specifically provided by the Committee, Non-Qualified Stock Options, shall be
exercisable only by such recipient. If the Committee approves provisions in any
particular case allowing for assignment or transfer of a Non-Qualified Stock
Option, then such option will nonetheless be subject to a six-month holding
period commencing on the date of grant during which period the recipient will
not be permitted to assign or transfer such option, unless the Committee further
specifically provides for the assignability or transferability of such option
during this period.

          (f) Effect of Termination of Employment. If a recipient's employment
(or service as an officer, director or consultant) shall terminate for any
reason, other than death or Retirement (as defined below), the right of the
recipient to exercise any option otherwise exercisable on the date of such
termination shall expire unless such right is exercised within a period of 90
days after the date of such termination. For Options issued prior to June 15,
2005, the term "Retirement" shall mean the voluntary termination of employment
(or service as an officer, director or consultant) by a recipient who has
attained the age of 55 and who has completed at least five years of service with
the Company. For Options issued on or after June 15, 2005, unless otherwise
determined by the Committee and defined in the applicable Award Agreement, the
term "Retirement" shall mean the voluntary termination of employment (or service
as an officer, director or consultant) by a recipient who has attained the age
of 60 and who has completed at least twenty years of service with the Company.
If a recipient's employment (or service as an officer, director or consultant)
shall terminate because of death or Retirement, the right of the recipient to
exercise any option otherwise exercisable on the date of such termination shall
be unaffected by such termination and shall continue until the normal expiration
of such option. Notwithstanding the foregoing, the tax treatment available
pursuant to Section 421 of the Code upon the exercise of an Incentive Stock
Option will not be available in connection with the exercise of any Incentive
Stock Option more than three months after the date of termination of such option
recipient's employment due to Retirement. Option rights shall not be affected by
any change of employment as long as the recipient continues to be employed by

                                        4

<PAGE>

either the Company or a parent or subsidiary of the Company. In no event,
however, shall an option be exercisable after the expiration of its original
term as determined by the Committee. The Committee may, if it determines that to
do so would be in the Company's best interests, provide in a specific case or
cases for the exercise of options which would otherwise terminate upon
termination of employment with the Company for any reason, upon such terms and
conditions as the Committee determines to be appropriate. Nothing in the Plan or
in any Award Agreement shall confer any right to continue in the employ of the
Company or any parent or subsidiary of the Company or interfere in any way with
the right of the Company or any parent or subsidiary of the Company to terminate
the employment of a recipient at any time.

          (g) Leave of Absence. In the case of a recipient on an approved leave
of absence, the Committee may, if it determines that to do so would be in the
best interests of the Company, provide in a specific case for continuation of
options during such leave of absence, such continuation to be on such terms and
conditions as the Committee determines to be appropriate, except that in no
event shall an option be exercisable after 10 years from the date it is granted.

          (h) Sale or Reorganization. In case the Company is merged or
consolidated with another corporation, or in case the property or stock of the
Company is acquired by another corporation, or in case of a reorganization, or
liquidation of the Company, the Board of Directors of the Company, or the board
of directors of any corporation assuming the obligations of the Company
hereunder, shall either (i) make appropriate provisions for the protection of
any outstanding options by the substitution on an equitable basis of appropriate
stock of the Company, or appropriate options to purchase stock of the merged,
consolidated, or otherwise reorganized corporation, provided only that such
substitution of options shall, with respect to Incentive Stock Options, comply
with the requirements of Section 424(a) of the Code, or (ii) give written notice
to optionees that their options, which will become immediately exercisable
notwithstanding any waiting period otherwise prescribed by the Committee, must
be exercised within 30 days of the date of such notice or they will be
terminated.

          (i) Restrictions on Sale of Shares. Without the written consent of the
Company, no stock acquired by an optionee upon exercise of an Incentive Stock
Option granted hereunder may be disposed of by the optionee within two years
from the date such incentive stock option was granted, nor within one year after
the transfer of such stock to the optionee; provided, however, that a transfer
to a trustee, receiver, or other fiduciary in any insolvency proceeding, as
described in Section 422(c)(3) of the Code, shall not be deemed to be such a
disposition. The optionee shall make appropriate arrangements with the Company
for any taxes which the Company is obligated to collect in connection with any
such disposition, including any federal, state, or local withholding taxes. No
stock acquired by an optionee upon exercise of a Non-Qualified Stock Option
granted hereunder may be disposed of by the optionee (or other person eligible
to exercise the option) within six months from the date such Non-Qualified Stock
Option was granted, unless otherwise provided by the Committee.

                                        5

<PAGE>

7.   GRANT OF STOCK APPRECIATION RIGHTS

     The Committee may grant Stock Appreciation Rights to such persons eligible
under the Plan as the Committee may select from time to time. Stock Appreciation
Rights shall be granted at such times, in such amounts and under such other
terms and conditions as the Committee shall determine, which terms and
conditions shall be evidenced under an Award Agreement, subject to the terms of
the Plan. Subject to the terms and conditions of the Award Agreement, a Stock
Appreciation Right shall entitle the award recipient to exercise the Stock
Appreciation Right, in whole or in part, in exchange for a payment of shares of
Common Stock, cash or a combination thereof, as determined by the Committee and
provided under the Award Agreement, equal in value to the excess of the Fair
Market Value of the shares of Common Stock underlying the Stock Appreciation
Right, determined on the date of exercise, over the base amount set forth in the
Award Agreement for shares of Common Stock underlying the Stock Appreciation
Right, which base amount shall not be less than the Fair Market Value of such
Common Stock, determined as of the date the Stock Appreciation Right is granted.

8.   GRANT OF RESTRICTED STOCK

     The Committee may grant Restricted Stock awards to such persons eligible
under the Plan as the Committee may select from time to time. Restricted Stock
awards shall be granted at such times, in such amounts and under such other
terms and conditions as the Committee shall determine, which terms and
conditions shall be evidenced under an Award Agreement, subject to the terms of
the Plan. The Award Agreement shall set forth any conditions on vesting and
restrictions on transferability that the Committee may determine is appropriate
for the Restricted Stock award, including the performance of future services or
satisfaction of performance goals established by the Committee. The books and
records of the Company shall reflect the issuance of shares of Common Stock
under a Restricted Stock award and any applicable restrictions and limitations
in such manner as the Committee determines is appropriate. Unless otherwise
provided in the Award Agreement, a recipient of a Restricted Stock award shall
be the record owner of the shares of Common Stock to which the Restricted Stock
relates and shall have all voting and dividend rights with respect to such
shares of Common Stock.

9.   GRANT OF STOCK BONUS

     The Committee may grant Stock Bonus awards to such persons eligible under
the Plan as the Committee may select from time to time. Stock Bonus awards shall
be granted at such times, in such amounts and under such other terms and
conditions as the Committee shall determine, which terms and conditions shall be
evidenced under an Award Agreement, subject to the terms of the Plan. Upon
satisfaction of any conditions, limitations and restrictions set forth in the
Award Agreement, a Stock Bonus award shall entitle the recipient to receive
payment of a bonus described under the Stock Bonus award in the form of shares
of Common Stock of the Company. Prior to the date on which a Stock Bonus award
is required to be paid under an Award Agreement, the Stock Bonus award shall
constitute an unfunded, unsecured promise by the Company to distribute Common
Stock in the future.

                                        6

<PAGE>

10.  ADJUSTMENTS IN THE EVENT OF RECAPITALIZATION

     In the event that dividends payable in Common Stock during any fiscal year
of the Company exceed in the aggregate five percent of the Common Stock issued
and outstanding at the beginning of the year, or in the event there is during
any fiscal year of the Company one or more splits, subdivisions, or combinations
of shares of Common Stock resulting in an increase or decrease by more than five
percent of the shares outstanding at the beginning of the year, the number of
shares available under the Plan shall be increased or decreased proportionately,
as the case may be, and the number of shares issuable under Stock Awards
theretofore granted shall be increased or decreased proportionately, as the case
may be, without change in the aggregate purchase price that may be applicable
thereto. Common Stock dividends, splits, subdivisions, or combinations during
any fiscal year that do not exceed in the aggregate five percent of the Common
Stock issued and outstanding at the beginning of such year shall be ignored for
purposes of the Plan. All adjustments shall be made as of the day such action
necessitating such adjustment becomes effective.

11.  WITHHOLDING OF APPLICABLE TAXES

     It shall be a condition to the performance of the Company's obligation to
issue or transfer Common Stock or make a payment of cash pursuant to any Stock
Award that the award recipient pay, or make provision satisfactory to the
Company for the payment of, any taxes (other than stock transfer taxes) the
Company or any subsidiary is obligated to collect with respect to the issuance
or transfer of Common Stock or the payment of cash under such Stock Award,
including any applicable federal, state, or local withholding or employment
taxes.

12.  GENERAL RESTRICTIONS

     Each Stock Award granted under the Plan shall be subject to the requirement
that, if at any time the Board of Directors shall determine, in its discretion,
that the listing, registration, or qualification of the shares of Common Stock
issuable or transferable under the Stock Award upon any securities exchange or
under any state or federal law, or the consent or approval of any governmental
regulatory body is necessary or desirable as a condition of, or in connection
with, the granting of the Stock Award or the issue or transfer, of shares of
Common Stock thereunder, shares of Common Stock issuable or transferable under
any Stock Award shall not be issued or transferred, in whole or in part, unless
such listing, registration, qualification, consent, or approval shall have been
effected or obtained free of any conditions not acceptable to the Board of
Directors.

     The Company shall not be obligated to sell or issue any shares of Common
Stock in any manner in contravention of the Securities Act, the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), the rules and regulations
of the Securities and Exchange Commission, any state securities law, the rules
and regulations promulgated thereunder or the rules and regulations of any
securities exchange or over the counter market on which the Common Stock is
listed or in which it is included for quotation. The Board of Directors may, in
connection with the granting of Stock Awards, require the individual to whom the
award is to be granted to enter into an agreement with the Company stating that
as a condition precedent to the receipt of shares of Common Stock

                                        7

<PAGE>

issuable or transferable under the Stock Award, in whole or in part, he shall,
if then required by the Company, represent to the Company in writing that such
receipt is for investment only and not with a view to distribution, and also
setting forth such other terms and conditions as the Committee may prescribe.
Such agreements may also, in the discretion of the Committee, contain provisions
requiring the forfeiture of any Stock Awards granted and/or Common Stock held,
in the event of the termination of employment or association, as the case may
be, of the award recipient with the Company. Upon any forfeiture of Common Stock
pursuant to an agreement authorized by the preceding sentence, the Company shall
pay consideration for such Common Stock to the award recipient , pursuant to any
such agreement, without interest thereon.

13.  TERMINATION AND AMENDMENT OF THE PLAN

     The Board of Directors or the Committee shall have the right to amend,
suspend, or terminate the Plan at any time; provided, however, that no such
action shall affect or in any way impair the rights of a recipient under any
Stock Award theretofore granted under the Plan; and, provided, further, that
unless first duly approved by the stockholders of the Company entitled to vote
thereon at a meeting (which may be the annual meeting) duly called and held for
such purpose, except as provided in Section 10, no amendment or change shall be
made in the Plan increasing the total number of shares which may be issued or
transferred under the Plan, materially increasing the benefits to Plan
participants or modifying the requirements as to eligibility for participation
in the Plan.

14.  TERM OF THE PLAN

     The Plan shall terminate on June 12, 2011, or on such earlier date as the
Board of Directors or the Committee may determine. Any Stock Award outstanding
at the termination date shall remain outstanding until it has either expired or
been exercised or cancelled pursuant to its terms.

15.  COMPLIANCE WITH RULE 16B-3

     With respect to persons subject to Section 16 of the Exchange Act,
transactions under this Plan are intended to comply with all applicable
conditions of Rule 16b-3 or its successors. To the extent any provision of the
Plan or action by the Committee (or any other person on behalf of the Committee
or the Company) fails to so comply, it shall be deemed null and void, to the
extent permitted by law and deemed advisable by the Committee.

                                        8

<PAGE>

16.  RIGHTS AS A STOCKHOLDER

     A recipient of a Stock Award shall have no rights as a stockholder with
respect to any shares issuable or transferable thereunder until the date a stock
certificate is issued to him for such shares unless otherwise provided in the
Award Agreement under the Plan. Except as otherwise expressly provided in the
Plan, no adjustment shall be made for dividends or other rights for which the
record date is prior to the date such stock certificate is issued.

17.  AUTOMATIC GRANT OF OPTIONS TO NON-EMPLOYEE DIRECTORS

          (a) (i) Each director, who is not also an employee of the Company or
any of its affiliates, or the designee of any stockholder of the Company
pursuant to a right to designate one or more directors (an "Eligible Director")
who first becomes an Eligible Director on or after June 13, 2001 but prior to
January 1, 2003, shall automatically be awarded a grant of 30,000 Non-Qualified
Stock Options upon his or her initial election to the Board of Directors. An
Eligible Director receiving an initial option grant under this Section 17(a)(i)
shall not be eligible for an initial grant of option under any other stock
option plan maintained by the Company. Such options shall vest and be
exercisable solely in accordance with the following schedule:

               (A) The options may be exercised with respect to a maximum of
one-half of the option shares during the twelve-month period beginning after the
date of grant.

               (B) The options may be exercised with respect to all of the
option shares upon the Eligible Director's reelection to the Board of Directors
for a second consecutive term.

               (C) The options will expire and will no longer be exercisable as
of the tenth anniversary of the date of grant, subject to sooner expiration upon
the occurrence of certain events as provided elsewhere in this Plan.

               (ii) Each Eligible Director who first becomes an Eligible
Director on or after January 1, 2003, shall automatically be awarded a grant of
50,000 Non-Qualified Stock Options upon his or her initial election to the Board
of Directors. An Eligible Director receiving an initial option grant under this
Section 17(a)(ii) shall not be eligible for an initial grant of option under any
other stock option plan maintained by the Company. Such options shall vest and
be exercisable solely in accordance with the following schedule:

               (A) The options shall not be exercisable during the twelve-month
period beginning after the date of grant.

               (B) The options may be exercised with respect to one-third of the
option shares after the expiration of twelve months from the date of grant.

               (C) The remaining two-thirds of the options shall vest and become
exercisable ratably on a monthly basis over the two-year period commencing one
year from the date of grant and ending three years from the date of grant.

                                        9

<PAGE>

               (D) The options will expire and will no longer be exercisable as
of the tenth anniversary of the date of grant, subject to sooner expiration upon
the occurrence of certain events as provided elsewhere in this Plan.

          (b) In addition to the grant provided in subsection (a), each Eligible
Director who first became an Eligible Director on or after June 13, 2001 shall
automatically be awarded a grant of Non-Qualified Stock Options upon each
reelection of such Eligible Director to a subsequent, successive term, in the
amount of an option for 7,500 shares.

          (c) Except to the extent an option is granted under any automatic
grant provision of any other stock option plan maintained by the Company, each
Eligible Director who first became an Eligible Director prior to June 13, 2001
shall automatically be awarded a grant of Non-Qualified Stock Options upon the
reelection of such Eligible Director to a third or subsequent, successive term,
in the amount and at the times hereinafter set forth. The number of options to
which each Eligible Director shall be entitled pursuant to this subsection (c)
shall be as follows:

               (i) 20,000 on the date of the Eligible Director's reelection to a
third one-year term;

               (ii) 20,000 on the date of the Eligible Director's reelection to
a fourth one-year term;

               (iii) 15,000 on the date of the Eligible Director's reelection to
a fifth one-year term;

               (iv) 15,000 on the date of the Eligible Director's reelection to
a sixth one-year term;

               (v) 10,000 on the date of the Eligible Director's reelection to a
seventh one-year term;

               (vi) 10,000 on the later of the date of the annual meeting of
stockholders in 2000, or the date of the Eligible Director's reelection to an
eighth one-year term;

               (vii) 10,000 on the later of the date of the annual meeting of
stockholders in 2001, or the date of the Eligible Director's reelection to a
ninth one-year term; and

               (viii) 7,500 on the date of the Eligible Director's reelection to
a tenth one-year term and on each successive reelection to a one-year term
thereafter.

          (d) Options granted pursuant to subsections (b) or (c) shall vest and
be exercisable solely in accordance with the following schedule:

                                       10

<PAGE>

               (i) The options shall not be exercisable during the twelve-month
period beginning after the date of grant.

               (ii) The options may be exercised with respect to one-third of
the option shares after the expiration of twelve months from the date of grant.

               (iii) The remaining two-thirds of the options shall vest and
become exercisable ratably on a monthly basis over the two-year period
commencing one year from the date of grant and ending three years from the date
of grant.

               (iv) The options will expire and will no longer be exercisable as
of the tenth anniversary of the date of grant, subject to sooner expiration upon
the occurrence of certain events as provided elsewhere in this Plan.

          (e) The option price for all options awarded under this Section 17
shall be equal to 100% of the Fair Market Value of a share of Common Stock on
the date of grant.

18.  OPTIONS GRANTED TO EMPLOYEES AND DIRECTORS OF ANY SUBSIDIARY IN THE UK

     In addition to the provisions above, the provisions of this Section 18
shall apply as herein set out to options granted to employees and directors of
any subsidiary in the United Kingdom. The provisions of this Section 18 enable
the Plan to be used in a tax efficient manner in the United Kingdom.

          (a) In this Section 18, the following terms have the meanings ascribed
to them:

          "Election" means an election in the form envisaged in Paragraph 3B(1)
of Schedule 1 to SSCBA and acceptable to the UK Subsidiary to the effect that
any Secondary NIC arising on the exercise, assignment or release of a UK Option
shall be the liability of the recipient and not the liability of the UK
Subsidiary

          "Independent Transfer Agent" means any person (other than the Company
or any company affiliated with the Company or any individual affiliated with any
such company) who is registered as a broker-dealer with the U.S. Securities and
Exchange Commission and who is thereby able to sell and transfer shares in the
Company on behalf of the Optionholder

          "Optionholder" means an employee or director of the UK Subsidiary who
is the holder of a UK Option

          "Secondary NIC" means secondary national insurance contributions as
defined in the SSCBA

          "SSCBA" means the Social Security Contributions and Benefits Act 1992
of the United Kingdom

                                       11

<PAGE>

          "UK Option" means an option granted to an employee of the UK
Subsidiary

          "UK Subsidiary" means OSI Pharmaceuticals (UK) Limited (a company
incorporated in England under company number 1709877) and any other UK
Subsidiary of the Company from time to time.

          (b) To the extent that it is lawful to do so, a UK Option may be
granted subject to a condition that any liability of the UK Subsidiary (as
employer or former employer of the relevant Optionholder) to pay Secondary NIC
in respect of the exercise, assignment or release of that UK Option shall be the
liability of the relevant Optionholder and payable by that Optionholder and that
the Optionholder shall not be entitled to exercise the UK Option until he has
entered into an Election to that effect when required to do so by the UK
Subsidiary provided that the Committee may in its discretion at any time or
times release the Optionholder from this liability or reduce his liability
thereunder unless that Election has been entered into between the UK Subsidiary
and that Optionholder and that Election (or the legislation which provides for
such an Election to be effective) does not allow for such an Election to be
subsequently varied.

          (c) If a UK Option is granted subject to the condition referred to in
paragraph (b) above then the Optionholder shall by completing the Election grant
to the UK Subsidiary (as employer or former employer of the relevant
Optionholder) the irrevocable authority, as agent of the Optionholder and on his
behalf, to appoint an Independent Transfer Agent, to act as agent of the
Optionholder and on his behalf, to sell or procure the sale of sufficient of the
Stock subject to the UK Option and remit the net sale proceeds to the UK
Subsidiary so that the net proceeds payable to the UK Subsidiary are so far as
possible equal to but not less than the amount of the Secondary NIC for which
the Optionholder is liable under the terms of the Election and the UK Subsidiary
shall account to the Optionholder for any balance.

               No Stock shall be allotted or transferred to the Optionholder by
the Company until the UK Subsidiary has received an amount in cash equal to the
amount of the Secondary NIC for which the Optionholder is liable under the terms
of the Election.

          (d) If a UK Option is exercised and the Optionholder is liable to tax
duties or other amounts on such exercise and the UK Subsidiary (as his employer
or former employer) is liable to make a payment to the appropriate authorities
on account of that liability, then the Optionholder shall by having completed
the option agreement grant to the UK Subsidiary (as employer or former employer
of the relevant Optionholder) the irrevocable authority, as agent of the
Optionholder and on his behalf, to appoint an Independent Transfer Agent, to act
as agent of the Optionholder and on his behalf, to sell or procure the sale of
sufficient of the Shares subject to the UK Option and remit the net sale
proceeds to the UK Subsidiary so that the net proceeds payable to the UK
Subsidiary are so far as possible equal to but not less than the amount payable
to the appropriate authorities and the UK Subsidiary shall account to the
Optionholder for any balance.

               No Stock shall be allotted or transferred to the Optionholder by
the Company until the UK Subsidiary has received an amount in cash equal to the
amount of any liability of the UK Subsidiary referred to in this paragraph (d).

                                       12<PAGE>

                                                                   Exhibit 10.32

                 COMPENSATORY ARRANGEMENTS OF EXECUTIVE OFFICERS

     On December 8, 2005, the Compensation Committee (the "Committee") of the
Board of Directors of OSI Pharmaceuticals, Inc. ("OSI" or the "Company")
approved the 2006 annual base salaries and 2005 cash bonuses for OSI's executive
officers including the Company's named executive officers (as that term is
defined in Item 402 of Regulation S-K) as set forth in OSI's proxy statement
dated February 2, 2005. The following table sets forth the annual base salary
levels of such officers for 2006 as compared to 2005 as well as the 2005 cash
bonuses for each such officer:

<TABLE>
<CAPTION>
                                                          2006 BASE
NAME AND POSITION                                           SALARY    2005 BONUS
-----------------                                         ---------   ----------
<S>                                                       <C>         <C>
Colin Goddard, Ph.D.                                       $600,000          --
Chief Executive Officer (1)

Michael G. Atieh                                           $410,000    $250,000
Executive Vice President, Chief Financial Officer
   and Treasurer (2)

Gabriel Leung                                              $400,000    $160,000
Executive Vice President and President, (OSI) Oncology

David Guyer, M.D.                                          $525,000         n/a
Executive Vice President and CEO, (OSI) Eyetech (3)

Anker Lundemose, M.D., Ph.D., D.Sc.                        L195,000    L 75,000
Executive Vice President and President, (OSI) Prosidion

Robert Simon                                               $347,998    $100,000
Executive Vice President, Pharmaceutical Development
   and Technical Operations

Barbara A. Wood                                            $320,000    $100,000
Vice President, General Counsel and Secretary

Neil Gibson, Ph.D.                                         $292,000    $ 90,000
Chief Scientific Officer (4)
</TABLE>

(1)  Given the performance of the Company's stock in 2005, the Committee
     concurred with Dr. Goddard's recommendation that he not receive a 2006
     bonus or merit increase to his base salary.

(2)  Mr. Atieh commenced employment as Executive Vice President, Chief Financial
     Officer and Treasurer on May 31, 2005. Mr. Atieh's bonus for 2005 was
     guaranteed as part of his employment contract signed in June, 2005.

(3)  Dr. Guyer became an employee of the Company on November 14, 2005 upon the
     consummation of the acquisition of Eyetech Pharmaceuticals, Inc. As per
     contract, the determination of 2005 bonuses for former Eyetech employees
     will be made by the Committee in February 2006.

(4)  Dr. Gibson assumed the role of Chief Scientific Officer on September 20,
     2005.

Bonuses

     The 2005 bonus awards were computed in accordance with the Committee's
policy of awarding annual bonuses for executive officers, as previously
disclosed, and are consistent with past practice. For purposes of compensation
decisions for 2005, the Committee measured the Company's performance and that of
each executive officer in fiscal year 2005 against goals established by the
executive officers and ratified by the Committee under the Company's Annual
Business Plan prior to the start of the fiscal year. The Company's bonus plan
awards executives for performance as individuals against personal goals and for
achievement of company goals.

<PAGE>

Bonus awards for executives are discretionary but generally follow guidelines
that recognize both corporate and personal goal attainment. In general, where an
individual or corporate bonus is awarded the award ranges between 80 and 150% of
the individual's target. For 2005, the Company performance component was set at
80%.

     The bonus targets for the executive officers are either set in accordance
with their employment agreements or are based upon their respective grade
levels. The current bonus targets (which represents a percentage of base salary)
for the executive officers are:

<TABLE>
<CAPTION>
NAME                                  TARGET
----                                  ------
<S>                                   <C>
Colin Goddard, Ph.D.                     *
Michael G. Atieh                        50%
Gabriel Leung                           50%
David Guyer, M.D.                       50%
Anker Lundemose, M.D., Ph.D., D.Sc.     50%
Robert Simon                            40%
Barbara Wood                            40%
Neil Gibson                             40%
</TABLE>

*    No specified target; determined by the Committee in its discretion.

Stock Option Grants

     Executive officers are eligible for awards of stock options or shares of
stock pursuant to the Company's Amended and Restated Stock Incentive Plan. Such
awards are made at the discretion of the Committee.

     Annual stock option grants for executive officers are a key element of the
executive officer's total compensation. As for all Company employees, the stock
option grants made annually to the executive officers are made in accordance
with the Company's formula-based policy for granting options. According to the
formula, each grade level is assigned a grant multiple. The number of options
granted to an executive officer is determined by multiplying the executive
officer's salary by the grant multiple and then dividing the product by a stock
price which is determined by the CEO and ratified by the Committee and is
typically a 3-6 month trailing average.

     Perquisites

     The only perquisite granted to executive officers which is not available to
other employees relates to the use of automobiles and is in the form of either
the payment of a car lease or, in lieu thereof, a monthly cash payment.
Currently, Mr. Atieh is the only executive officer who does not receive the
perquisites.

                                       -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]